Skip to main content

A2A Pharmaceuticals, Inc.

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists A2A Pharmaceuticals, Inc. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 2, 2023 (view filing)May 31-Jun 12 daysA2A Pharmaceuticals, Inc.10% OwnerSSale−125.0K$34.11−$4.26M−3.4%3.50M after2 lots
May 17, 2023 (view filing)May 125 daysLateA2A Pharmaceuticals, Inc.10% OwnerSSale−25.0K$33.84−$846.0K−0.7%3.63M after
May 10, 2023 (view filing)May 8-92 daysA2A Pharmaceuticals, Inc.10% OwnerSSale−250.0K$34.30−$8.57M−6.4%3.65M after2 lots
Apr 26, 2023 (view filing)Apr 206 daysLateA2A Pharmaceuticals, Inc.10% OwnerSSale−200.0K$29.12−$5.82M−4.9%3.90M after
Apr 6, 2023 (view filing)Mar 316 daysA2A Pharmaceuticals, Inc.10% OwnerSSale−200.0K$31.25−$6.25M−4.7%4.10M afterAmended
Aug 19, 2022 (view filing)Aug 163 daysLateA2A Pharmaceuticals, Inc.10% OwnerPPurchase−30.7K$13.87−$425.6K−0.7%4.30M after
Jul 25, 2022 (view filing)Jul 214 daysA2A Pharmaceuticals, Inc.10% OwnerSSale−34.7K$11.21−$388.5K−0.8%4.33M after
Jun 28, 2022 (view filing)Jun 244 daysA2A Pharmaceuticals, Inc.10% OwnerSSale−34.7K$11.76−$407.6K−0.8%4.37M after
Sep 21, 2021 (view filing)Sep 174 daysA2A Pharmaceuticals, Inc.10% OwnerPPurchase+34.7K$10.96+$379.9K+0.8%4.40M afterDuplicate filing